Literature DB >> 11442322

Amyotrophic lateral sclerosis: pathogenesis.

R H Brown1, W Robberecht.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating paralytic disorder caused by motor neuron degeneration. A subgroup of familial cases arises from mutations in the gene encoding cytosolic superoxide dismutase (SOD1). This review considers insight now being gained into ALS pathogenesis from the study of mutant SOD1 protein and its possible mechanisms of adverse effect on nerve cells. Also discussed are the status of other genetic forms of ALS and the elusive question of why this disorder so specifically targets motor neurons. Ultimately, it is hoped that insights from these types of studies will improve the prospects for developing meaningful therapies of ALS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442322     DOI: 10.1055/s-2001-15260

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  30 in total

1.  A possible therapeutic target for Lou Gehrig's disease.

Authors:  Soumya S Ray; Peter T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

2.  Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis.

Authors:  Radhia Benmohamed; Anthony C Arvanites; Jinho Kim; Robert J Ferrante; Richard B Silverman; Richard I Morimoto; Donald R Kirsch
Journal:  Amyotroph Lateral Scler       Date:  2010-11-12

Review 3.  Redox modifier genes and pathways in amyotrophic lateral sclerosis.

Authors:  Barrie J Carter; Pervin Anklesaria; Stephanie Choi; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

4.  Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity.

Authors:  SoHui Kim; Sónia S Leal; Daniel Ben Halevy; Cláudio M Gomes; Sima Lev
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

5.  Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G⁹³A transgenic ALS mice.

Authors:  P Hande Ozdinler; Susanna Benn; Ted H Yamamoto; Mine Güzel; Robert H Brown; Jeffrey D Macklis
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

6.  Substituted pyrazolones require N2 hydrogen bond donating ability to protect against cytotoxicity from protein aggregation of mutant superoxide dismutase 1.

Authors:  Paul C Trippier; Radhia Benmohamed; Radhia Benmohammed; Donald R Kirsch; Richard B Silverman
Journal:  Bioorg Med Chem Lett       Date:  2012-09-07       Impact factor: 2.823

7.  Transplanted modified muscle progenitor cells expressing a mixture of neurotrophic factors delay disease onset and enhance survival in the SOD1 mouse model of ALS.

Authors:  M Dadon-Nachum; K Ben-Yaacov; T Ben-Zur; Y Barhum; D Yaffe; E Perlson; D Offen
Journal:  J Mol Neurosci       Date:  2014-10-21       Impact factor: 3.444

8.  The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model.

Authors:  Haruhisa Inoue; Kayoko Tsukita; Takuji Iwasato; Yasuyuki Suzuki; Masanori Tomioka; Minako Tateno; Masahiro Nagao; Akihiro Kawata; Takaomi C Saido; Masayuki Miura; Hidemi Misawa; Shigeyoshi Itohara; Ryosuke Takahashi
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

9.  Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models.

Authors:  Eun Jin Yang; Jing Hua Jiang; Sang Min Lee; Sun Choel Yang; Hye Suk Hwang; Myeong Soo Lee; Sun-Mi Choi
Journal:  J Neuroinflammation       Date:  2010-10-15       Impact factor: 8.322

10.  Neuroprotective and Angiogenic Effects of Bone Marrow Transplantation Combined With Granulocyte Colony-Stimulating Factor in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Yasuyuki Ohta; Makiko Nagai; Kazunori Miyazaki; Nobuhito Tanaka; Hiromi Kawai; Takafumi Mimoto; Nobutoshi Morimoto; Tomoko Kurata; Yoshio Ikeda; Tohru Matsuura; Koji Abe
Journal:  Cell Med       Date:  2011-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.